chr5-141573886-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005219.5(DIAPH1):​c.1964C>G​(p.Pro655Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000568 in 1,545,202 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P655A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00029 ( 0 hom., cov: 26)
Exomes 𝑓: 0.00060 ( 10 hom. )

Consequence

DIAPH1
NM_005219.5 missense

Scores

3
7
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 8.93

Publications

0 publications found
Variant links:
Genes affected
DIAPH1 (HGNC:2876): (diaphanous related formin 1) This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
DIAPH1 Gene-Disease associations (from GenCC):
  • DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal dominant nonsyndromic hearing loss 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009348184).
BP6
Variant 5-141573886-G-C is Benign according to our data. Variant chr5-141573886-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 542368.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000291 (44/151448) while in subpopulation SAS AF = 0.00755 (36/4770). AF 95% confidence interval is 0.0056. There are 0 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIAPH1NM_005219.5 linkc.1964C>G p.Pro655Arg missense_variant Exon 16 of 28 ENST00000389054.8 NP_005210.3 O60610-1Q6URC4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIAPH1ENST00000389054.8 linkc.1964C>G p.Pro655Arg missense_variant Exon 16 of 28 5 NM_005219.5 ENSP00000373706.4 O60610-1
DIAPH1ENST00000518047.5 linkc.1937C>G p.Pro646Arg missense_variant Exon 15 of 27 5 ENSP00000428268.2 O60610-3
DIAPH1ENST00000647433.1 linkc.1964C>G p.Pro655Arg missense_variant Exon 16 of 29 ENSP00000494675.1 A0A2R8Y5N1
DIAPH1ENST00000647330.1 linkn.*1191C>G downstream_gene_variant ENSP00000494308.1 A0A2R8YEF8

Frequencies

GnomAD3 genomes
AF:
0.000297
AC:
45
AN:
151338
Hom.:
0
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.000170
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00775
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00147
AC:
221
AN:
149862
AF XY:
0.00200
show subpopulations
Gnomad AFR exome
AF:
0.000239
Gnomad AMR exome
AF:
0.0000410
Gnomad ASJ exome
AF:
0.000683
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000101
Gnomad OTH exome
AF:
0.00119
GnomAD4 exome
AF:
0.000598
AC:
833
AN:
1393754
Hom.:
10
Cov.:
37
AF XY:
0.000835
AC XY:
573
AN XY:
686390
show subpopulations
African (AFR)
AF:
0.0000626
AC:
2
AN:
31964
American (AMR)
AF:
0.0000283
AC:
1
AN:
35382
Ashkenazi Jewish (ASJ)
AF:
0.000167
AC:
4
AN:
24022
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36338
South Asian (SAS)
AF:
0.00947
AC:
731
AN:
77182
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48704
Middle Eastern (MID)
AF:
0.00390
AC:
22
AN:
5642
European-Non Finnish (NFE)
AF:
0.0000139
AC:
15
AN:
1076662
Other (OTH)
AF:
0.00100
AC:
58
AN:
57858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
54
108
162
216
270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000291
AC:
44
AN:
151448
Hom.:
0
Cov.:
26
AF XY:
0.000406
AC XY:
30
AN XY:
73960
show subpopulations
African (AFR)
AF:
0.000170
AC:
7
AN:
41244
American (AMR)
AF:
0.00
AC:
0
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00755
AC:
36
AN:
4770
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10558
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67760
Other (OTH)
AF:
0.00
AC:
0
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000528
Hom.:
0
Bravo
AF:
0.0000793
ExAC
AF:
0.000852
AC:
94
Asia WGS
AF:
0.00664
AC:
23
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DIAPH1: BP4, BS2 -

Mar 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

DIAPH1-related disorder Benign:1
Mar 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.030
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
T;.;T;.;T;.
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.71
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.76
T;T;T;T;T;T
MetaRNN
Benign
0.0093
T;T;T;T;T;T
MetaSVM
Uncertain
0.029
D
MutationAssessor
Benign
1.8
L;.;.;.;.;.
PhyloP100
8.9
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.4
N;.;N;N;N;N
REVEL
Uncertain
0.38
Sift
Uncertain
0.029
D;.;D;T;T;D
Sift4G
Uncertain
0.0020
D;.;D;D;D;D
Polyphen
1.0
D;.;.;.;.;.
Vest4
0.45
MutPred
0.56
Loss of glycosylation at P655 (P = 0.0029);Loss of glycosylation at P655 (P = 0.0029);.;.;Loss of glycosylation at P655 (P = 0.0029);.;
MVP
0.95
MPC
0.12
ClinPred
0.061
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.12
gMVP
0.28
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367669306; hg19: chr5-140953453; API